Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998;17(3):345-68.
doi: 10.1007/BF02786456.

Thymopentin and splenopentin as immunomodulators. Current status

Affiliations
Review

Thymopentin and splenopentin as immunomodulators. Current status

V K Singh et al. Immunol Res. 1998.

Abstract

Splenopentin (SP-5, Arg-Lys-Glu-Val-Tyr) and thymopentin (TP-5, Arg-Lys-Asp-Val-Tyr) are synthetic immunomodulating peptides corresponding to the region 32-34 of a splenic product called splenin (SP) and the thymic hormone thymopoietin (TP), respectively. TP was originally isolated as a 5-kDa (49-amino acids) protein from bovine thymus while studying effects of the thymic extracts on neuromuscular transmission and was subsequently observed to affect T cell differentiation and function. TP I and II are two closely related polypeptides isolated from bovine thymus. A radioimmunoassay for TP revealed a crossreaction with a product found in spleen and lymph node. This product, named splenin, differs from TP only in position 34, aspartic acid for bovine TP and glutamic acid for bovine splenin and it was called TP III as well. Synthetic pentapeptides (TP-5) and (SP-5), reproduce the biological activities of TP and SP, respectively. It is now evident that various forms of TPs were created by proteolytic cleavage of larger proteins during isolation. cDNA clones have been isolated for three alternatively spliced mRNAs that encodes three distinct human T cell TPs. The immunomodulatory properties of TP, SP, TP-5, SP-5 and some of their synthetic analogs reported in the literature have been briefly reviewed.

PubMed Disclaimer

References

    1. Lancet. 1983 Mar 12;1(8324):551-4 - PubMed
    1. Int J Immunopharmacol. 1995 Mar;17(3):207-12 - PubMed
    1. Biochem Mol Biol Int. 1994 Nov;34(5):927-33 - PubMed
    1. Breast Cancer Res Treat. 1993 Sep;27(3):221-37 - PubMed
    1. Fiziol Zh (1994). 1994 Jan-Feb;40(1):100-5 - PubMed

Publication types

MeSH terms

LinkOut - more resources